| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/01/2005 | US20050191742 Trophoblast cell preparations |
| 09/01/2005 | US20050191740 Using tissue specific gene transfer element as tool in somatic gene therapy |
| 09/01/2005 | US20050191702 Immunoglobulin comprising chemokine receptor binding domain and T cell surface polypeptide for use in prevention and treatment of nervous system, skin, diabetes, graft versus host, inflammatory joint and autoimmune diseases |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191681 Nucleotide sequences coding secretory proteins for use in diagnosis, prevention and treatment of nervous system, inflammatory, cell proliferative, cardiovascular and blood disorders |
| 09/01/2005 | US20050191680 Therapeutic nucleic acid-3' -conjugates |
| 09/01/2005 | US20050191672 Nucleotide sequences for use in controlling expression of serine/threonine kinase and treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular and skin disorders |
| 09/01/2005 | US20050191661 Treatment of inflammatory disease by cleaving TNF receptors |
| 09/01/2005 | US20050191653 Oligonucleotide for use in controlling expression of sodium-dependent glucose cotransporters (SGLT2) gene sequenes and treatment of diabetes |
| 09/01/2005 | US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders |
| 09/01/2005 | US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders |
| 09/01/2005 | US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 09/01/2005 | US20050191618 chemically synthesized double stranded siNA against HIV-1 or HIV-2 RNA; treatment of HIV infection or AIDS |
| 09/01/2005 | US20050191617 Pramyxovirusl vectors encoding antibody and utilization thereof |
| 09/01/2005 | US20050191358 Microparticles with adsorbed polynucleotide-containing species |
| 09/01/2005 | US20050191344 Imidazolyl Derivatized Distearoylphosphatidylethanolamine for delivery of a polyanionic compound, such as a nucleic acid, polynucleotide, a polysaccharide or a negatively charged protein to a cell |
| 09/01/2005 | US20050191316 Neisseria genomic sequences and methods of their use |
| 09/01/2005 | US20050191312 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma |
| 09/01/2005 | US20050191304 Employing Zvegf3 antagonists |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191298 Administering an anti-C5 antibody for treating paroxysmal nocturnal hemoglobinuria blood disorder; reduction in lactate dehydrogenase; biodrug for hemoglobinuria, anemia, hemoglobinemia, dysphagia, fatigue, nitric oxide (NO) deficiency, erectile dysfunction, recurrent abdominal pain and thrombosis |
| 09/01/2005 | US20050191283 Methods of treating NFAT-related disorders |
| 09/01/2005 | US20050191282 In polyvinylpyrrolidone cryoprotectant medium |
| 09/01/2005 | US20050191278 Coronary artery disease treatment |
| 09/01/2005 | US20050191277 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 09/01/2005 | CA2788707A1 Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 09/01/2005 | CA2558682A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 09/01/2005 | CA2557595A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 09/01/2005 | CA2557424A1 Methods for protein production |
| 09/01/2005 | CA2556803A1 T cell immune response inhibitor |
| 09/01/2005 | CA2556435A1 Anti-microrna oligonucleotide molecules |
| 09/01/2005 | CA2556425A1 Methods of modulating il-23 activity; related reagents |
| 09/01/2005 | CA2555984A1 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 09/01/2005 | CA2555421A1 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders |
| 09/01/2005 | CA2555236A1 Methods of modulating cytokine activity; related reagents |
| 08/31/2005 | EP1568779A1 HSV strains for the oncolytic treatment of cancer |
| 08/31/2005 | EP1568769A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 08/31/2005 | EP1568708A2 Methods and medical uses of nucleic acids encoding a TRAF inhibitor |
| 08/31/2005 | EP1568383A2 Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment |
| 08/31/2005 | EP1568376A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 08/31/2005 | EP1568375A1 Use of VEGF-C or VEGF-D gene or protein to prevent restenosis |
| 08/31/2005 | EP1567662A2 Caged sensors, regulators and compounds and uses thereof |
| 08/31/2005 | EP1567653A2 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 08/31/2005 | EP1567644A2 Tissue specific genes and gene clusters |
| 08/31/2005 | EP1567641A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 08/31/2005 | EP1567552A2 Novel ifngamma-like polypeptides |
| 08/31/2005 | EP1567539A2 Allele-specific rna interference |
| 08/31/2005 | EP1567198A2 Materials and methods for treating ocular-related disorders |
| 08/31/2005 | EP1567197A2 Compositions for treating or preventing angiogenesis-dependent symptoms |
| 08/31/2005 | EP1567196A2 Modulation of notch3 expression |
| 08/31/2005 | EP1567194A1 Hypercoiling polymers and their use in cellular delivery |
| 08/31/2005 | EP1567187A1 Proteins involved in the regulation of energy homeostasis |
| 08/31/2005 | EP1567160A2 Method of treatment of myocardial infarction |
| 08/31/2005 | EP1567157A1 Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 08/31/2005 | EP1567009A2 Antisense modulation of notch (drosophila) homolog 4 expression |
| 08/31/2005 | EP1567007A2 Compositions and methods for cancer diagnosis and therapy |
| 08/31/2005 | EP1259264A4 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/31/2005 | EP1173475B1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 08/31/2005 | EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 08/31/2005 | CN1662703A Appts. and method for extracting kraft paper pulp and atuomatically defibering |
| 08/31/2005 | CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| 08/31/2005 | CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 08/31/2005 | CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 08/31/2005 | CN1662261A Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ( |
| 08/31/2005 | CN1661373A New target drone of medication for anti hepatitis b virus and application |
| 08/31/2005 | CN1660911A Connective tissue growth factor fragments and methods and uses thereof |
| 08/31/2005 | CN1660421A Bobtail bacterin of neuraminidase for preventing influenza virus and preparing method |
| 08/31/2005 | CN1216909C Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method |
| 08/31/2005 | CN1216640C Live vaccine for human immunodeficiency virus |
| 08/31/2005 | CN1216618C A TCM compound recipe notoginseng capsule and method for preparing the same |
| 08/30/2005 | US6936729 Activation |
| 08/30/2005 | US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping |
| 08/30/2005 | US6936691 Secreted protein HCE3C63 |
| 08/30/2005 | US6936595 Tumour-specific vector for gene therapy |
| 08/30/2005 | US6936594 Gene therapy for cerebrovascular disorders |
| 08/30/2005 | US6936467 Nucleotide sequences for use in the repair of genetic damage |
| 08/30/2005 | US6936466 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders |
| 08/30/2005 | US6936465 Plasmid vector comprising a retroviral integrase gene and an integrase recognition region |
| 08/30/2005 | US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule |
| 08/30/2005 | US6936425 Attenuated salmonella SP12 mutants as antigen carriers |
| 08/30/2005 | US6936424 Materials and methods for detection and treatment of breast cancer |
| 08/30/2005 | US6936418 Methods and compositions for effecting homologous recombination |
| 08/30/2005 | US6936276 For tissue regeneration, applying a multilayer biodegradable matrix of crosslinked proteins and/or polysaccharides, where each layer has porosity to accomodate living cells; bone, joint, cartilage repair |
| 08/30/2005 | US6936243 Adeno-associated viral vector-mediated delivery of DNA to cells of the liver |
| 08/26/2005 | CA2456595A1 Process for identifying eukariotic tumor cells or bacteria arboring a genomic alteration in at least one part of a gene encoding for a transcription factor |
| 08/25/2005 | WO2005078123A1 Diagnostics and therapeutics for diseases associated with kallikrein 5 (klk5) |
| 08/25/2005 | WO2005078099A1 Mecp2e1 gene |
| 08/25/2005 | WO2005078096A2 Dual functional oligonucleotides for use in repressing mutant gene expression |
| 08/25/2005 | WO2005078087A1 Antibody targeting osteoclast-associated protein |
| 08/25/2005 | WO2005078084A1 Polyion complex carrying double stranded oligonucleic acid, process for producing the same and pharmaceutical composition containing the same |
| 08/25/2005 | WO2005078081A1 Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof |
| 08/25/2005 | WO2005077423A2 Adept or gdept producing acetaldehyde |
| 08/25/2005 | WO2005077412A2 Compositions and methods of use of w-peptides |
| 08/25/2005 | WO2005077337A2 Dispersions prepared by use of self-stabilizing agents |
| 08/25/2005 | WO2005077333A2 Gel-based delivery of recombinant adeno-associated virus vectors |
| 08/25/2005 | WO2005077126A2 Use of ppargamma specific inhibitors as anti-cancer therapeutics |
| 08/25/2005 | WO2005077006A2 Methods and compositions for detecting and treating retinal diseases |
| 08/25/2005 | WO2005076981A2 Methods and compositions related to neuronal differentiation |
| 08/25/2005 | WO2005055945A3 Mucoadhesive drug delivery devices and methods of making and using thereof |